JAMA
What The Study Did:
This randomized clinical trial compares the effects of once-weekly subcutaneous semaglutide versussplacebo for weight management as an adjunct to intensive behavioral therapy with initial low-calorie diet in adults with overweight or obesity.
Authors:
Thomas A. Wadden, Ph.D., of the University of Pennsylvania in Philadelphia, is the corresponding author.
To access the embargoed study:
Visit our For The Media website at this link
https:/
(doi:10.1001/jama.2021.1831)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
###
